San Francisco, CA, United States of America

Weimin Zhu

This inventor holds 19 USPTO granted patents and 7 published patent applications and 5 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Apexigen, Inc., Epitomics, Inc., Jiangsu Simcere Pharmaceutical R&d Co., Ltd. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weimin Zhu. Retrieved from https://idiyas.com/inventor/weimin-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 7)

% Patents Active = 94.7

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 105(Granted Patents)

Location History:

Burlingame, CA (US) (2015)
Millbrae, CA (US) (2016 - 2019)
San Francisco, CA (US) (2008 - 2021)

Company Filing History:

Jiangsu Simcere Pharmaceutical R&d Co., Ltd

patents

where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...

Areas of Expertise:

Anti-CD40 Antibodies

Monoclonal Antibody Generation

Anti-RANKL Antibodies

High Throughput Screening

Fusion Partner

Anti-VEGF Antibodies

B Cell Panning

Pharmaceutical Composition

Polynucleotides

Cancer Cell Proliferation

Methods of Use

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11001637 - Anti-CD40 antibodies (2021-05-11),

2. 10934524 - High throughput monoclonal antibody generation by B cell panning and proliferation (2021-03-02),

3. 10377814 - Fusion partner for production of monoclonal rabbit antibodies (2019-08-13),

4. 10259878 - Anti-RANKL antibodies and methods of use (2019-04-16),

5. 9994640 - Anti-CD40 antibodies (2018-06-12),

6. 9676861 - Anti-CD40 antibodies and methods of use (2017-06-13),

7. 9556278 - Anti-CD40 antibodies (2017-01-31),

8. 9441042 - Anti-KDR antibodies and methods of use (2016-09-13),

9. 9328333 - Fusion partner for production of monoclonal rabbit antibodies (2016-05-03),

10. 9266956 - Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies (2016-02-23),

11. 8986692 - Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody (2015-03-24),

12. 8957193 - Polynucleotides encoding anti-CD40 antibodies (2015-02-17),

13. 8778345 - Anti-CD40 antibodies (2014-07-15),

14. 8367408 - Fusion partner for production of monoclonal rabbit antibodies (2013-02-05),

15. 8088375 - Anti-VEGF antibody (2012-01-03),

Title: The Innovative Journey of Inventor Weimin Zhu

Introduction: Weimin Zhu, a pioneering female inventor based in San Francisco, CA, has made significant contributions to the field of technology through her groundbreaking inventions and patents.

Latest Patents: Weimin Zhu's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a background in engineering and a passion for innovation, Weimin Zhu has a successful career marked by numerous patents in various technological domains. Her ability to blend creativity with technical expertise has led to the development of products that have positively impacted society.

Collaborations: Throughout her career, Weimin Zhu has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her collaborative spirit and dedication to excellence have resulted in successful partnerships that have furthered technological advancements.

Conclusion: Weimin Zhu's relentless pursuit of innovation and her commitment to pushing the boundaries of technology make her a standout figure in the world of inventors. Her contributions continue to inspire future generations of inventors and pave the way for a more technologically advanced future.

Profile summary based on public USPTO records.